Autologous Stem Cell Therapy Service
Discover what makes our adipose-tissue-derived stem cell therapy (ASCT) service different from other UK providers.
Rethink surgery, reduce risk
The UK’s first Certified Autologous Stem Cell Therapy service for MSK Specialists, doctors and surgeons. A certification of analysis demonstrates the quality, quantity and purity of a patient’s cells.
Prescribe your patients with stem cell medicines within your field of expertise to treat a wide range of conditions – where there is a clearly established medical need. Patients’ stem cells are multiplied to more than 20 times their original concentration. The stem cells are sterile, infection risk-free and ready to be delivered back to your clinic to be administered to your patient. Prescribers may combine stem cells with shockwave therapy (ESWT) treatments to further accelerate healing.
"MSCs are known to have the ability to enhance wound healing, reduce inflammation and, in the laboratory, rescue dying cells. In clinical trials they have been shown to enhance cartilage repair and bone formation. Stem cells have become the corner stone of regenerative medicine, significantly reducing the number of operative procedures a patient may require."
Professor Ash Mosahebi
What does Autologous mean?
Autologous Stem Cell therapy is the process of using a patient’s own adult stem cells, also known as somatic stem cells.
LifePlus uses cells derived from fatty (adipose) tissue. Stem cells are then processed, increasing the concentration, quantity and quality by more than 20 times, before being re-administered to the same patient for a variety of medical conditions.
What sets our service apart?
Our manufacturing and culture process increases the quantity and quality of the harvested cells by more than 20 times.
We work with leading biotechnologists, utilising a unique methodology all overseen by industry experts.
We provide every stem cell treatment run with a full and detailed manufacturing analysis of quantity, purity and potency.
How does this differ to bedside centrifuge techniques?
Other autologous techniques, use a ‘one-size-fits-all’ bedside ball bearing shaker device or centrifuge approach, which merely separates fat from stem cells, re-injecting the same quantity of cells back into the patient – the actual number of stem cells never changes.
Such techniques do not multiply the cells, the cells are not analysed and the patient will not be provided with a certificate of analysis.
With LifePlus the extraction and isolation of adipose fat stem cells is performed through aspiration from the lower abdomen. The adipose tissue can be extracted in large quantities using an aspiration device (containing approx. 100 thousand stem cells) these cells will be grown and expanded in a GMP cleanroom facility (pharmaceutical standard) for up to 10 days, reaching quantities of up to 20 million cells. After this process, stem cells can be returned to the prescriber to be re-introduced to the patient as potential mediators of anti-inflammatory and enhanced wound healing effects in orthopaedics and plastic surgery.